Cancer Council Australia2026EN
Clinical Practice Guidelines for the Treatment of Lung Cancer
Zusammenfassung
This PDF has been made available for reference only.
Please note that these guidelines have been developed as electronic guidelines and published at:
We are aware that the formatting in this PDF is not perfect. It has been produced for offline review purposes only
These guidelines have been developed as web-based guidelines and the pdf serves as a
reference copy only. Please note that this material is only current to the date and time
stamped on this document.
PDF generated at: 15:46, 22.07
Kerninformationen
n based chemotherapy as effective as cisplatin based chemotherapy for
treatment of stage IV inoperable NSCLC? ............................................................................................................. 22
7. Clinical question:Is chemotherapy with a biologic or targeted therapy sup...
.......................................................................................................... 43
14. Clinical question:What is the best practice radiotherapy approach in patients with stage I inoperable NSCLC?
.............................................................................
................. 72
20. Clinical question:What is the clinical benefit of radiotherapy in metastatic spinal cord compression? ........... 80
21. Clinical question:What is the clinical benefit of radiotherapy to the bone for metastatic disease from NSCLC? .
84
22. Clinical question:What is the clin...
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchenVerwandte Leitlinien
SIGN2014
SIGN 137: Management of lung cancer
AWMF2025
AWMF 020-007OL: Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms - Living Guideline
Leitlinienprogramm Onkologie2024
S3-Leitlinie Lungenkarzinom v2.2 (2024)
Cochrane2024
Cochrane Review: Therapeutic vaccines for advanced non-small cell lung cancer
Cochrane2023
Cochrane Review: Best first-line therapy for people with advanced non-small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status
Onkopedia2025
Onkopedia: Lungenkarzinom, kleinzellig (SCLC)
Onkopedia2025